Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.10M | 6.99M | 9.03M | 8.59M | 12.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.10M | 6.99M | 9.03M | 8.59M | 12.56M |
| Cost of Revenue | 3.01M | 2.05M | 2.64M | 3.27M | 5.27M |
| Gross Profit | 14.09M | 4.94M | 6.39M | 5.32M | 7.29M |
| SG&A Expenses | 8.75M | 10.37M | 10.60M | 8.66M | 8.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.54M | 13.27M | 14.11M | 13.14M | 14.27M |
| Operating Income | 4.56M | -6.28M | -5.08M | -4.55M | -1.71M |
| Income Before Tax | 5.64M | -6.64M | -5.30M | -4.20M | -1.40M |
| Income Tax Expenses | 0.00 | 6.00K | 21.00K | -1.00K | -3.00K |
| Earnings from Continuing Operations | 5.64M | -6.65M | -5.32M | -4.20M | -1.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.64M | -6.65M | -5.32M | -4.20M | -1.40M |
| EBIT | 4.56M | -6.28M | -5.08M | -4.55M | -1.71M |
| EBITDA | 4.62M | -6.26M | -5.05M | -4.52M | -1.68M |
| EPS Basic | 0.48 | -0.62 | -0.57 | -0.47 | -0.18 |
| Normalized Basic EPS | 0.26 | -0.39 | -0.35 | -0.30 | -0.12 |
| EPS Diluted | 0.48 | -0.62 | -0.57 | -0.47 | -0.18 |
| Normalized Diluted EPS | 0.26 | -0.39 | -0.35 | -0.30 | -0.12 |
| Average Basic Shares Outstanding | 11.66M | 10.78M | 9.35M | 8.87M | 7.57M |
| Average Diluted Shares Outstanding | 11.66M | 10.78M | 9.35M | 8.87M | 7.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |